Results 81 to 90 of about 413,265 (135)

Premature Ventricular Complexes With 2 QRS Morphologies: Cardiac Crux Insights and an Endocardial Ablation Strategy. [PDF]

JACC Case Rep
Vo TD, Nguyen MN, Lin CY.
europepmc   +1 more source

Cyclic Thrombocytopenia Complicated by Thrombosis and Successfully Treated With Rituximab: A Diagnostic and Therapeutic Challenge. [PDF]

J Brown Hosp Med
Nicacio JM, Diniz LFB, Fernandes ALM.
europepmc   +1 more source

Progression of Cutis Marmorata Following Initial Hyperbaric Therapy for Decompression Sickness. [PDF]

Respirol Case Rep
Liang SW, Tang SE, Wu CH.
europepmc   +1 more source

Lung function impairment at pulmonary TB and HIV/TB diagnosis: a South African cross-sectional cohort analysis. [PDF]

BMJ Open Respir Res
Marll M, Ngwanto T, Mofokeng N, Mngomezulu L, El Sammak S, Rajaratnam A, Willis F, Magee M, Gabuza L, Kornfeld H, Li Y, Maenetje P, Bisson GP, Auld S.   +13 more
europepmc   +1 more source

Single-nucleus transcriptomics resolves multiple fate dynamics between inflorescence meristem and primary stem. [PDF]

Sci Adv
Moreno-Ramírez S, Lenz MO, Meyerowitz EM, Locke JCW, Jönsson H.   +4 more
europepmc   +1 more source

Color Graphics: Can Everyone See Them? [PDF]

Cell Mol Gastroenterol Hepatol
Geng Y, Ortiz V.
europepmc   +1 more source

3D imaging reveals robustness and plasticity of cell division in rice early embryogenesis. [PDF]

Plant Cell Physiol
Tezuka M, Kitta T, Kumakura H, Sato M, Kamamoto N, Naramoto S, Tsuji H, Okamoto T, Kinoshita A.   +8 more
europepmc   +1 more source

MajesTEC-3: Redefining what's possible in multiple myeloma. [PDF]

Clin Hematol Int
Al Hadidi S, Gaballa M.
europepmc   +1 more source

Prognostic Effect of TTF-1 Expression and Histopathology in the Patients with Advanced Lung Adenocarcinoma Treated with Immunochemotherapy. [PDF]

Kobe J Med Sci
Iwamoto N, Yamada J, Jimbo N, Yamasaki N, Hatakeyama Y, Kiriu T, Matsumura K, Katsurada M, Okuno K, Nakata K, Tachihara M.   +10 more
europepmc   +1 more source

Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy. [PDF]

JCO Oncol Pract
Othus M, Truong TG, Sharon E, Kendra K, Grossmann K, Buchbinder E, Khushalani NI, Eroglu Z, Chandra S, Doolittle GC, Kirkwood JM, Ikeguchi A, Mihalcioiu C, Cowey CL, Reddy SA, Johnson DB, Taylor M, Sondak VK, Ribas A, Patel SP.   +19 more
europepmc   +1 more source